MDSpire - Takeaway
Commentary & Perspectives

"We Need Better Answers in Glaucoma"

Leading 2026 Power Lister Gus Gazzard on collaboration, data quality, and trial design

  • March 31, 2026

  • 5 min

Share

  • 1

    Gaps exist in glaucoma treatment innovation and testing capabilities.

  • 2

    Collaboration among clinicians is vital for effective trial outcomes.

  • 3

    Registry-based trials can improve efficiency and patient involvement.

  • 4

    Fragility Indices and WIN ratios are emerging tools for trial robustness.

  • 5

    AI can enhance outcomes but is not essential for immediate improvements.

Original Source(s)

"We Need Better Answers in Glaucoma"

  • March 31, 2026

Related Content

Equal Pay in Ophthalmology? Not Yet

A decade of AAMC salary data reveals a persistent gender pay gap in academic ophthalmology—and projects it will never close at senior ranks

IOL Calculation Formulas: What Should the Ophthalmologist Expect？

Matching modern IOL formulas to axial length for optimal outcomes

Metformin’s Potential Role in Posterior Capsule Opacification

Common diabetes therapy reaches intraocular lens tissue and may help limit PCO, says newly published data

  • March 30, 2026

  • 3 min